Fullcircle Wealth »

Summit Therapeutics shares owned by Fullcircle Wealth

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Fullcircle Wealth from 13F filings

Historical chart of Fullcircle Wealth investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Fullcircle Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Fullcircle Wealth

Quarter filed Position value Share count Share price at filing
2024-09-30 $250k 11k 22.24
2024-06-30 $122k 12k 9.98

More positions owned by Fullcircle Wealth

United Parcel Service CL B (UPS)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Apple (AAPL)
Microsoft Corporation (MSFT)
Goldman Sachs Etf Tr Acces Treasury (GBIL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Snowflake Cl A (SNOW)
Ishares Tr Ibonds 24 Trm Ts (IBTE)
Ishares Tr Core Total Usd (IUSB)
Ishares Tr Core S&p500 Etf (IVV)
Unilever Spon Adr New (UL)
Spdr Ser Tr Bloomberg High Y (JNK)
Texas Instruments Incorporated (TXN)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Ishares Tr S&p 500 Grwt Etf (IVW)

View all positions for Fullcircle Wealth

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
BlackRock
BlackRock
T. Rowe Price Associates
State Street Corporation
Geode Capital Management
Jane Street
Susquehanna International
Citadel Advisors
Charles Schwab Investment Management
Standard Life Aberdeen
Darwin Global Management
Balyasny Asset Management
Northern Trust

View all funds holding Summit Therapeutics